Roble, Belko & Company, Inc - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 116 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 4.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Roble, Belko & Company, Inc ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$7,000
+40.0%
2,0630.0%0.00%0.0%
Q4 2018$5,000
-58.3%
2,0630.0%0.00%
-50.0%
Q3 2018$12,000
+20.0%
2,0630.0%0.00%0.0%
Q2 2018$10,000
-28.6%
2,0630.0%0.00%
-20.0%
Q1 2018$14,000
-12.5%
2,0630.0%0.01%
-28.6%
Q4 2017$16,0002,0630.01%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,196,527$16,526,0003.00%
BVF INC/IL 5,328,239$27,547,0001.08%
Soleus Capital Management, L.P. 740,000$3,826,0000.60%
Cutter & CO Brokerage, Inc. 326,100$1,686,0000.40%
EAM Investors, LLC 288,459$1,491,0000.25%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$5,316,0000.15%
Rhenman & Partners Asset Management AB 300,000$1,551,0000.11%
Navis Wealth Advisors, LLC 16,000$83,0000.06%
Sigma Planning Corp 364,484$1,884,0000.06%
XTX Topco Ltd 32,650$169,0000.06%
View complete list of PIERIS PHARMACEUTICALS INC shareholders